HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

benzylsuccinic acid

inhibitor of carboxypeptidase A

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Dicarboxylic Acids: 108
      - Succinates: 13
        benzylsuccinic acid: 2

Experts

1.	Hamada, Takatoshi: 1 article (03/2007)
2.	Kumada, Takashi: 1 article (03/2007)
3.	Matsugi, Shinji: 1 article (03/2007)
4.	Satomura, Shinji: 1 article (03/2007)
5.	Shioi, Noriko: 1 article (03/2007)
6.	Tanaka, Takumi: 1 article (03/2007)

Related Diseases

1.	Chronic Pancreatitis 03/01/2007 - "Serum CPA from 406 patients including 169 with pancreatic carcinoma, 53 with acute pancreatitis, 23 with chronic pancreatitis, and 161 with non-pancreatic diseases were assayed by a method with N-acetyl-phenylalanyl-l-3-thiaphenylalanine as substrate and dl-benzylsuccinic acid as specific inhibitor of CPA. "
2.	Pancreatitis 03/01/2007 - "Serum CPA from 406 patients including 169 with pancreatic carcinoma, 53 with acute pancreatitis, 23 with chronic pancreatitis, and 161 with non-pancreatic diseases were assayed by a method with N-acetyl-phenylalanyl-l-3-thiaphenylalanine as substrate and dl-benzylsuccinic acid as specific inhibitor of CPA. "
3.	Pancreatic Neoplasms (Pancreatic Cancer) 03/01/2007 - "Serum CPA from 406 patients including 169 with pancreatic carcinoma, 53 with acute pancreatitis, 23 with chronic pancreatitis, and 161 with non-pancreatic diseases were assayed by a method with N-acetyl-phenylalanyl-l-3-thiaphenylalanine as substrate and dl-benzylsuccinic acid as specific inhibitor of CPA. "
4.	Pancreatic Diseases (Pancreatic Disease) 03/01/2007 - "Serum CPA from 406 patients including 169 with pancreatic carcinoma, 53 with acute pancreatitis, 23 with chronic pancreatitis, and 161 with non-pancreatic diseases were assayed by a method with N-acetyl-phenylalanyl-l-3-thiaphenylalanine as substrate and dl-benzylsuccinic acid as specific inhibitor of CPA. "
5.	Type 2 Diabetes Mellitus (MODY) 01/01/2004 - "Mitiglinide [KAD 1229, S 21403], a derivative of benzylsuccinic acid, is a potassium channel antagonist undergoing development with Kissei for the treatment of type 2 diabetes mellitus. "

Related Drugs and Biologics

1.	Potassium Channels (Potassium Channel)
2.	mitiglinide